30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Calidi Biotherapeutics Inc (CLDI)

Track

Stock chart
Ticker: CLDI Exchange: ASE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Camaisa Allan
1 sale — total 1,237 USD
Sale 12 Dec 2025
Value US$4,816,777.20 | Price 416.72 | Shares 792
Buy 21 Aug 2025
Value US$3,731,553.95 | Price 91.61 | Shares 29,498
Buy 21 Aug 2025
Value US$250,000.00 | Price 2.00 | Shares 125,000
Buy 21 Aug 2025
Value US$50,000.00 | Price 2.00 | Shares 25,000
Buy 21 Aug 2025
Value US$150,000.00 | Price 2.00 | Shares 75,000
Sale 17 Dec 2024
Value US$16,200.00 | Price 1.62 | Shares 10,000
Sale 19 Oct 2022
Value US$358,380.00 | Price 9.90 | Shares 36,200
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-12-16 2025-12-12 S Sale
3.9
Camaisa Allan
Non-Executive Director
792 +16.5%
416.72
US$4,816,777 		792 +16.5% 416.72 US$4,816,777
2025-08-25 2025-08-21 B Purchase
2.2
Jackson Andrew C.

Chief Financial Officer

Officer
29,498 +26.0%
91.61
US$3,731,554 		29,498 +26.0% 91.61 US$3,731,554
2025-08-25 2025-08-21 B Purchase
Leftwich Scott
Non-Executive Director
73,210 -1.7%
22.55
US$4,444,932 		73,210 -1.7% 22.55 US$4,444,932
2025-08-25 2025-08-21 B Purchase
Poma Eric E

Chief Executive Officer

Executive Director
25,000 +inf%
2.00
US$50,000 		25,000 +inf% 2.00 US$50,000
2025-08-25 2025-08-21 B Purchase
3.1
Schoeneck James A
Non-Executive Director
75,000 +6613.8%
2.00
US$150,000 		75,000 +6613.8% 2.00 US$150,000
2024-12-18 2024-12-17 S Sale
3.9
Camaisa Allan

CEO and Chairman of the Board

Executive Director
10,000 -13.0%
1.62
US$16,200 		10,000 -13.0% 1.62 US$16,200
2022-10-21 2022-10-19 S Sale
2.3
Polar Asset Management Partners Inc.
Large shareholder
36,200 -8.1%
9.90
US$358,380 		36,200 -8.1% 9.90 US$358,380
Explore more

More insider trading research around Calidi Biotherapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America